P. Reche et al., EXPRESSION AND CHARACTERIZATION OF THE TRYPANOSOMA-CRUZI DIHYDROFOLATE-REDUCTASE DOMAIN, Molecular and biochemical parasitology, 76(1-2), 1996, pp. 175-185
We have cloned and expressed in Escherichia coli a 702-base pair gene
coding for the dihydrofolate reductase (DHFR) domain of the bifunction
al dihydrofolate reductase-thymidylate synthase (DHFR-TS) from Trypano
soma cruzi. The DHFR domain was purified to homogeneity by methotrexat
e-Sepharose chromatography followed by an anion-exchange chromatograph
y step in a mono Q column, and displayed a single 27-kDa band on SDS-P
AGE, Gel filtration showed that the catalytic domain was expressed as
a monomer. Kinetic parameters were similar to those reported for the w
ild-type bifunctional enzyme with K-m values of 0.75 mu M for dihydrof
olate and 16 mu M for NADPH and a k(cat) value of 16.5 s(-1). T. cruzi
DHFR is poorly inhibited by trimethoprim and pyrimethamine and the in
hibition constants were always lower for the bifunctional enzyme. The
binding of methotrexate was characteristic of a class of inhibitors th
at form an initial complex which isomerizes slowly to a tighter comple
x and are referred to as 'slow, tight-binding' inhibitors. While the s
low-binding step of inhibition was apparently unaffected in the indivi
dually expressed DHFR domain, the overall inhibition constant was two-
fold higher as a consequence of the superior inhibition constant value
obtained for the initial inhibitory complex.